Advertisement

Topics

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount https://reut.rs/2Duqaab 

17:27 EST 8 Nov 2018 | Reuters Health Twitter

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount https://reut.rs/2Duqaab 

Original Article: Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount https://reut.rs/2Duqaab 

NEXT ARTICLE

More From BioPortfolio on "Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount https://reut.rs/2Duqaab "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...